Company Filing History:
Years Active: 2004
Title: Innovator Lu Q Le: Pioneering Methods for Lymphocyte Modulation
Introduction: Lu Q Le is a distinguished inventor based in Los Angeles, California, who has made significant contributions to the field of immunology. With a focus on modulating G protein-coupled receptors (GPCRs), her work addresses critical issues related to cell proliferation, autoimmunity, and inflammation.
Latest Patents: Lu Q Le holds a patent titled "Methods for modulating the activation of a lymphocyte expressed G protein coupled receptor involved in cell proliferation, autoimmunity and inflammation." This invention details ligands and methodologies for influencing the activity of the G2A receptor, a lymphocyte-expressed GPCR. The unique findings indicate that lysophosphatidylcholine (LPC) acts as a high-affinity ligand, while sphingosylphosphorylcholine (SPC) serves as a lower affinity alternative. The implications of G2A activation extend to a broad range of physiological processes, unlocking potential diagnostic and therapeutic applications.
Career Highlights: Lu Q Le is affiliated with the University of California, a prestigious institution known for its groundbreaking research. Her innovative work has positioned her as a prominent figure in her field, focusing on a receptor that plays a pivotal role in autoimmune conditions. With one patent to her name, she exemplifies dedication and ingenuity in scientific advancement.
Collaborations: In her research endeavors, Lu has collaborated with esteemed colleagues Owen N Witte and Zhigang Weng. Their collective expertise fosters a stimulating environment that enhances the potential of their innovative projects and drives forward the understanding of G protein-coupled receptors.
Conclusion: Lu Q Le’s contributions to the field of immunology, particularly regarding G protein-coupled receptors, represent significant advancements in understanding cell behaviors linked to autoimmunity and inflammation. As her work continues to evolve, it promises to pave the way for novel therapeutic strategies that could benefit individuals affected by these conditions.